Synthesis of N6-substituted 9-[3-(phosphonomethoxy)propyl] adenine derivatives as possible antiviral agents

Nucleosides, Nucleotides and Nucleic Acids

Volumn 24, Issue 10-12, 2005, Pages 1597-1611

  El Kattan, Yahya ^a   Lin, Tsu Hsing ^a   Wu, Minwan ^a   Kumar, V Satish ^a   Kotian, Pravin L ^a   Ghosh, Ajit ^a   Cheng, Xiaogang ^a   Bantia, Shanta ^a   Babu, Yarlagadda S ^a   Chand, Pooran ^a  

^a BIOCRYST PHARMACEUTICALS INC   (United States)

Author keywords

Acyclic nucleosides; Antiviral; Prodrugs

Indexed keywords

9 [1 HYDROXYMETHYL [3 (DI TERT BUTYLCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 ALLYLAMINOPURINE; 9 [1 HYDROXYMETHYL [3 (DI TERT BUTYLCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 CYCLOPENTYLAMINOPURINE; 9 [1 HYDROXYMETHYL [3 (DI TERT BUTYLCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 ETHYLAMINOPURINE; 9 [1 HYDROXYMETHYL [3 (DIISOPROPYLOXYCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 CYCLOBUTYLAMINOPURINE; 9 [1 HYDROXYMETHYL [3 (DIISOPROPYLOXYCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 CYCLOPROPYLAMINOPURINE; 9 [1 HYDROXYMETHYL [3 (DIISOPROPYLOXYCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 DIETHYLAMINOPURINE; 9 [1 HYDROXYMETHYL [3 (DIISOPROPYLOXYCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 N AZETIDINOPURINE; 9 [1 HYDROXYMETHYL [3 (DIISOPROPYLOXYCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 N METHYL N ETHYLAMINOPURINE; 9 [1 HYDROXYMETHYL [3 (DIISOPROPYLOXYCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 N MORPHOLINOPURINE; 9 [1 HYDROXYMETHYL [3 (DIISOPROPYLOXYCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 N PHENYLAMINOPURINE; 9 [1 HYDROXYMETHYL [3 (DIISOPROPYLOXYCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 N PIPERIDINOPURINE; 9 [1 HYDROXYMETHYL [3 (DIISOPROPYLOXYCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 N PYRROLIDINOPURINE; 9 [1 HYDROXYMETHYL [3 (DIISOPROPYLOXYCARBONYLOXYMETHYLPHOSPHONO)METHOXY] PROPYL] 6 N THIAZOLIDINOPURINE; ADENINE DERIVATIVE; ANTIVIRUS AGENT; FUNCTIONAL GROUP; PRODRUG; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; HEPATITIS C VIRUS; NONHUMAN; REPLICON;

HEPATITIS C VIRUS;

EID: 29244486781     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770500265760     Document Type: Article

References (17)

1. Holy, A.; Dvorakova, H.; Jindrich, J.; Masojidkova, M.; Budesinsky, M.; Balzarini, J.; Andrei, G.; De Clercq, E. Acyclic nucleotide analogs derived from 8-azapurines: Synthesis and antiviral activity. J. Med. Chem. 1996, 39, 4073-4088.
2. Balzarini, J.; Pannecouque, C.; De Clercq, E.; Aquaro, S.; Perno, C.-F.; Egberink, H.; Holy, A. Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates. Antimicrob. Agents Chemother. 2002, 46, 2185-2193.
3. Balzarini, J.; Perno, C.F.; Schols, D.; De Clercq, E. Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes. Biochem. Biophys. Res. Commun. 1991, 178, 329-335.
4. De Clercq, E.; Holy, A.; Rosenberg, I.; Sakuma, T.; Balzarini, J.; Maudgal, P.C. A novel selective broad-spectrum anti-DNA virus agent. Nature 1986, 323, 464-467.
5. Naesens, L.; De Clercq, E. Therapeutic potential of HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues as broad-spectrum antiviral agents. Nucleosides Nucleotides 1997, 16, 983-992.
6. Balzarini, J.; Holy, A.; Jindrich, J.; Naesens, L.; Snoeck, R.; Schols, D.; De Clercq, E. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: Potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2- phosphonomethoxypropyl)-2,6-diaminopurine. Antimicrob. Agents Chemother. 1993, 37, 332-338.
7. Balzarini, J.; Aquaro, S.; Perno, C.-F.; Holy, A.; De Clercq, E. Activity of the (R)-enantiomers of 9-(2-phosphonyl-methoxypropyl)adenine and 9-(2-phosphonyl-methoxypropyl)-2,6-diamiriopurine against human immunodeficiency virus in different human cell systems. Biochem. Biophys. Res. Commun. 1996, 219, 337-341.
8. 1 adenosine receptor. J. Med. Chem. 2000, 43, 250-260.
9. 4 Substituted 1-β-D-ribofuranosylpyrazolo[3,4-d]pyrimidines as adenosine agonist analogues. J. Med. Chem. 1983, 26, 1601-1606.
10. Angeli, P.; Brasili, L.; Brancia, E.; Giardina, D.; Quaglia, W.; Melchiorre, C. Structure-activity relationships among benextramine-related tetraamine disulfides at peripheral α-adrenoreceptors. J. Med. Chem. 1985, 28, 1643-1647.
11. Carroll, S.S.; Tomassini, J.E.; Bosserman, M.; Getty, K.; Stahlhut, M.W.; Eldrup, A.B.; Bhat, B.; Hall, D.; Simcoe, A.L.; LaFemina, R.; Rutkowski, C.A.; Wolanski, B.; Yang, Z.; Migliaccio, G.; De Francesco, R.; Kuo, L.C.; MacCoss, M.; Olsen, D.B. Inhibition of hepatitis C virus RNA replication by 2′-modified nucleoside analogues. J. Biol. Chem. 2003, 278(14), 11979-11984.
12. Carroll, S.S.; LaFemina, R.; Hall, D.; Himmelberger, A.L.; Kuo, L.C.; MacCoss, M.; Olsen, D.B.; Rutkowski, C.A.; Tomassini, J.E.; An, H.; Bhat, B.; Bhat, N.; Cook, P.D.; Eldrup, A.B.; Guinosso C.J.; Prhavc, M.; Prakash, T.P. Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase. PCT Patent Appl. WO 02/057425 A2, 2002.
13. Ding, Y.; An, H. Deazapurine nucleoside analogs and their use as therapeutic agents. PCT Patent Appl. WO 03/061576 A2, 2003.
14. An, H.; Ding, Y.; Shaw, S.; Hong, Z. 2′-beta-modified-6-substituted adenosine analogs and their use as antiviral agents. PCT Patent Appl. WO 03/062256 A1, 2003.
15. Hong, Z.; An, H.; Ding, Y.; Girardet, J.L.; Zhong, W. Sugar modified nucleosides as viral replication inhibitors. PCT Patent Appl. WO 03/062255 A2, 2003.
16. An, H.; Hong, Z.; Smith, K.; Ding, Y.; Girardet, J.L. Tricyclic nucleoside library compounds, synthesis, and use as antiviral agents. PCT Patent Appl. WO 03/061385 A1, 2003.
17. Carroll, S.S.; Tomassini, J.E.; Bosserman, M.; Getty, K.; Stahlhut, M.W.; Eldrup, A.B.; Bhat, B.; Hall, D.; Simcoe, A.L.; LaFemina, R.; Rutkowski, C.A.; Wolanski, B.; Yang, Z.; Migliaccio, G.; De Francesco, R.; Kuo, L.C.; MacCoss, M.; Olsen, D.B. Inhibition of hepatitis C virus RNA replication by 2′-modified nucleoside analogs. J. Biol. Chem. 2003, 278, 11979-11984.